Getein Biotech Inc

603387 · SHG · Healthcare / Medical Devices

8.24CNY-0.31 (-3.63%)

Price History

Full chart

Market Stats

Previous Close8.55

Open8.51

Day Range8.21 – 8.55

52-Week Range7.37 – 11.42

Volume11.33M

Market Cap5.08B

P/E (TTM)16.97

Forward P/E0.00

EPS0.59

Dividend Yield3.00%

Beta-0.04

50-Day Avg9.29

200-Day Avg8.98

About

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection, infectious diseases, autoimmune diseases, universal blocking agents, and secondary antibodies. Getein Biotech, Inc was founded in 2002 and is headquartered in Nanjing, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Enben Su
Employees1.73K
HeadquartersNo.9 Bofu Road, Nanjing, China, 211505, China
Websitehttps://www.getein.com.cn

Leadership

Mr. Enben SuChairman & GM · b. 1966
Mr. Wen NiAccounting Supervisor & CFO · b. 1983
Ms. Tingting KongDeputy GM & Director · b. 1984
Mr. Bin YanDeputy GM & Director · b. 1982
Ms. Xu TangBoard Secretary · b. 1994

Financials

Income Statement

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	73.64M	154.20M	210.29M	276.42M	369.09M	488.58M	686.24M	968.20M	1.12B	1.40B	1.82B	1.37B	1.16B	1.05B
Growth (%)	-	+109.39%	+36.38%	+31.45%	+33.53%	+32.37%	+40.45%	+41.09%	+16.02%	+24.78%	+29.97%	-24.85%	-14.93%	-9.71%
Cost of Revenue	10.36M	25.91M	33.76M	47.51M	69.35M	88.62M	144.06M	264.90M	414.42M	485.42M	671.56M	479.71M	374.39M	317.73M
Gross Profit	63.28M	128.29M	176.53M	228.91M	299.74M	399.96M	542.18M	703.30M	708.92M	916.29M	1.15B	889.45M	790.41M	733.99M
Gross Margin	85.93%	83.20%	83.94%	82.81%	81.21%	81.86%	79.01%	72.64%	63.11%	65.37%	63.14%	64.96%	67.86%	69.79%
Operating Expense	41.62M	59.85M	95.63M	117.10M	147.10M	176.63M	259.39M	304.39M	330.92M	463.50M	587.05M	582.86M	532.36M	476.98M
Operating Income	21.66M	68.43M	80.90M	111.81M	152.64M	223.33M	282.79M	398.91M	378.00M	452.79M	563.26M	306.59M	258.05M	257.01M
Operating Margin	29.41%	44.38%	38.47%	40.45%	41.36%	45.71%	41.21%	41.20%	33.65%	32.30%	30.92%	22.39%	22.15%	24.44%
EBITDA	26.42M	77.49M	92.44M	120.28M	177.66M	246.47M	315.80M	425.34M	416.19M	513.39M	642.06M	407.92M	354.73M	325.14M
EBITDA Margin	35.88%	50.26%	43.96%	43.51%	48.13%	50.45%	46.02%	43.93%	37.05%	36.63%	35.24%	29.79%	30.45%	30.91%
Net Income	21.96M	65.63M	75.14M	105.07M	138.36M	193.99M	249.61M	339.67M	304.73M	398.99M	498.91M	279.77M	223.64M	220.66M
Net Income Margin	29.82%	42.56%	35.73%	38.01%	37.49%	39.70%	36.37%	35.08%	27.13%	28.46%	27.38%	20.43%	19.20%	20.98%
R&D	7.95M	14.00M	30.00M	31.92M	39.28M	54.04M	80.60M	104.73M	119.07M	163.39M	223.22M	217.99M	181.21M	157.40M
R&D as % of Total Revenue	10.79%	9.08%	14.27%	11.55%	10.64%	11.06%	11.74%	10.82%	10.60%	11.66%	12.25%	15.92%	15.56%	14.97%
Interest Expense	12.66K	0	25.17K	43.72K	55.85K	1.49M	120.87K	1.65M	7.17M	15.99M	17.15M	17.48M	15.42M	12.09M
Interest Expense % of Total Revenue	0.02%	0.00%	0.01%	0.02%	0.02%	0.30%	0.02%	0.17%	0.64%	1.14%	0.94%	1.28%	1.32%	1.15%

Balance Sheet

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	89.78M	154.49M	206.45M	328.08M	434.09M	1.27B	1.57B	2.01B	2.70B	3.14B	3.68B	3.77B	3.71B	3.76B
Total Liabilities	49.15M	70.42M	41.26M	59.48M	91.13M	118.87M	187.23M	325.98M	695.95M	863.90M	1.01B	1.03B	986.42M	896.55M
Total Equity	39.58M	84.06M	162.03M	266.50M	340.09M	1.14B	1.35B	1.62B	1.84B	2.11B	2.48B	2.56B	2.62B	2.75B
Cash	19.99M	10.53M	8.20M	11.43M	26.26M	301.03M	145.41M	659.48M	801.50M	968.90M	646.25M	484.33M	351.60M	313.88M
Total Debt	-	-	-	-	-	-	31.24M	95.00M	384.79M	496.47M	591.02M	644.00M	577.19M	-
Net Debt	-19.99M	-10.53M	-8.20M	-11.43M	-26.26M	-301.03M	-114.17M	-564.48M	-416.71M	-472.44M	-55.23M	159.67M	225.60M	166.01M

Cash Flow

Currency: CNY	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	23.80M	59.72M	98.53M	121.73M	155.91M	191.91M	187.10M	225.73M	185.47M	432.36M	482.96M	333.22M	423.00M	392.59M
Investing Cash Flow	-9.93M	-48.17M	-92.82M	-106.88M	-82.28M	-519.28M	-345.52M	261.76M	-238.71M	-254.63M	-760.44M	-356.83M	-348.12M	-
Financing Cash Flow	1.05M	-21.00M	-8.05M	-11.68M	-59.18M	602.84M	-1.51M	25.94M	200.00M	-28.93M	-45.88M	-145.88M	-213.67M	-
Capital Expenditure	10.39M	12.02M	70.09M	46.65M	39.31M	61.35M	110.74M	124.82M	113.53M	179.60M	217.44M	258.13M	156.40M	150.58M
Free Cash Flow	13.41M	47.69M	28.45M	75.08M	116.60M	130.56M	76.35M	100.92M	71.94M	252.77M	265.51M	75.09M	266.60M	242.01M
Dividends Paid	-	21.00M	11.18M	9.38M	59.28M	68.17M	59.80M	76.27M	104.15M	93.16M	123.17M	219.40M	110.98M	103.24M
FCF to OCF	56.34%	79.87%	28.87%	61.68%	74.78%	68.03%	40.81%	44.71%	38.79%	58.46%	54.98%	22.54%	63.03%	61.64%
Dividend Paid to FCF	-	44.03%	39.28%	12.49%	50.84%	52.21%	78.32%	75.57%	144.78%	36.86%	46.39%	292.18%	41.63%	42.66%

Earnings

Report Date	Oct 31, 2017	Apr 10, 2018	Aug 29, 2018	Oct 26, 2018	Apr 9, 2019	Aug 20, 2019	Oct 22, 2019	Mar 23, 2020	Apr 30, 2020	Aug 26, 2020	Oct 27, 2020	Mar 3, 2021	Apr 27, 2021	Aug 17, 2021	Oct 29, 2021	Apr 27, 2022	Aug 24, 2022	Oct 27, 2022	Apr 27, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	0.15	0.14	0.18	-	-	-	-	-
EPS Actual	0.10	0.13	0.13	0.10	0.17	0.14	0.09	0.38	0.09	0.10	0.20	0.22	0.12	0.18	0.23	0.28	0.22	0.29	0.05
Surprise	-	-	-	-	-	-	-	-	-	-	-	48.65%	-14.29%	0.00%	-	-	-	-	-
Timing	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	-	-	-

Key Statistics & Ratios

Market Cap5.08B

Enterprise Value3.71B

Trailing P/E16.97

Forward P/E0.00

Price / Sales4.64

Price / Book1.72

EPS0.59

Book Value5.80

Revenue (TTM)1.09B

Gross Profit (TTM)737.52M

EBITDA337.02M

Profit Margin27.06%

Operating Margin19.28%

Return on Equity10.02%

Return on Assets4.15%

Shares Outstanding507.15M

Shares Float282.74M

Beta-0.04

Dividend Yield3.00%

Dividend Rate0.30

Payout Ratio40.68%

Dividends

20231×

0.30Jun 2, 2023

20221×

0.34Jun 8, 2022

20211×

0.26Jun 23, 2021

20201×

0.20May 8, 2020

20191×

0.21May 21, 2019

20181×

0.16Jun 1, 2018

Stock Splits

Jun 8, 20227:5
Jun 23, 20217:5
May 21, 20197:5
Jun 1, 20187:5